Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024:1463:41-44.
doi: 10.1007/978-3-031-67458-7_7.

Cerebral Oximetry in the Neonatal Intensive Care Unit: Discussion of Two Contradicting Study Results (SafeBoosC-II, SafeBoosC-III)

Martin Wolf  1 , Marco Ferrari  2 , Felix Scholkmann  3   4
Affiliations

Cerebral Oximetry in the Neonatal Intensive Care Unit: Discussion of Two Contradicting Study Results (SafeBoosC-II, SafeBoosC-III)

Martin Wolf et al. Adv Exp Med Biol. 2024.

Abstract

Recently, the usefulness of near-infrared spectroscopy-based cerebral oximetry in extremely preterm infants to prevent death or severe brain injury was evaluated in a study called SafeBoosC-III (N = 1601). In this study, the incidence of both outcomes was similar between the cerebral oximetry and the control group. In a previous smaller study called SafeBoosC-II (N = 166), there was a borderline significant advantage for cerebral oximetry. There is therefore a highly significant (p = 0.010) difference between the two outcomes. What could be the reason for the difference? One major difference was that many centres were not familiar with cerebral oximeters in the new study compared with the old study. This could be a reason for the discrepancy. We conclude that cerebral oximetry should not be disregarded as a method of neuromonitoring in neonatology.

Keywords: Brain injury; Cerebral oximetry; Death; Near infrared spectroscopy; Preterm infants.

PubMed Disclaimer

References

    1. Wolf M, Ferrari M, Quaresima V (2007) Progress of near-infrared spectroscopy and topography for brain and muscle clinical applications. J Biomed Opt 12(6):062104 - DOI - PubMed
    1. Hansen ML et al (2023) Cerebral oximetry monitoring in extremely preterm infants. N Engl J Med 388(16):1501–1511 - DOI - PubMed
    1. Pellicer A et al (2013) The SafeBoosC phase II randomised clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infants. Neonatology 104(3):171–178 - DOI - PubMed
    1. Rasmussen MI et al (2023) Cerebral oximetry monitoring versus usual care for extremely preterm infants: a study protocol for the 2-year follow-up of the SafeBoosC-III randomised clinical trial. Trials 24(1)
    1. SafeBoosC-III (2023) Available from: https://www.rigshospitalet.dk/english/departments/juliane-marie-centre/d...

LinkOut - more resources